Back to top

Image: Bigstock

Strength Seen in Aptose (APTO): Stock Soars 5.3%

Read MoreHide Full Article

Aptose Biosciences Inc. (APTO - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continue the recent uptrend for the company — as the stock is now up 56.4% in the past one-month time frame.

The company has seen three positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Aptose. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Aptose currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Another stock in the Medical sector is Aerpio Pharmaceuticals, Inc. (ARPO - Free Report) , which currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Aptose Biosciences, Inc. (APTO) - free report >>

Aerpio Pharmaceuticals, Inc. (ARPO) - free report >>